Protalix BioTherapeutics, Inc. - PLX

All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)? Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).

Files summary

Total files loaded: 10
Latest filed: May 21, 2026
Form Count
8-K 7
SCHEDULE 13G/A 1
SCHEDULE 13G 1
4 1

Latest files

Filed Form Report period Accession SEC
May 21, 2026 8-K May 21, 2026 0001104659-26-064850 View
May 13, 2026 8-K May 13, 2026 0001104659-26-059749 View
Mar 30, 2026 SCHEDULE 13G/A 0001426156-26-000006 View
Mar 18, 2026 8-K Mar 18, 2026 0001104659-26-029846 View
Mar 09, 2026 8-K Mar 09, 2026 0001104659-26-024975 View
Mar 04, 2026 SCHEDULE 13G 0001426156-26-000002 View
Feb 11, 2026 8-K Feb 11, 2026 0001104659-26-013498 View
Jan 30, 2026 8-K Jan 30, 2026 0001104659-26-008410 View
Jan 05, 2026 8-K Jan 05, 2026 0001104659-26-000393 View
Dec 23, 2025 4 Dec 19, 2025 0001781450-25-000005 View